Rituximab, Bendamustine and Cytarabine (RBAC500) as Induction Therapy in Elderly Patients With Mantle Cell Lymphoma: A Phase 2 Study From the Fondazione Italiana Linfomi.

Rituximab, Bendamustine and Cytarabine (RBAC500) as Induction Therapy in Elderly Patients With Mantle Cell Lymphoma: A Phase 2 Study From the Fondazione Italiana Linfomi. Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):19-20 Authors: PMID: 26862877 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26862877?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - February 12, 2016 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research